Medy-Tox (XKRX:086900) Long-Term Debt : ₩0 Mil (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Medy-Tox Long-Term Debt?

Medy-Tox's Long-Term Debt for the quarter that ended in Dec. 2023 was ₩0 Mil.

Medy-Tox's quarterly Long-Term Debt declined from Jun. 2023 (₩10,000 Mil) to Sep. 2023 (₩5,000 Mil) and declined from Sep. 2023 (₩5,000 Mil) to Dec. 2023 (₩0 Mil).

Medy-Tox's annual Long-Term Debt declined from Dec. 2021 (₩55,057 Mil) to Dec. 2022 (₩20,000 Mil) and declined from Dec. 2022 (₩20,000 Mil) to Dec. 2023 (₩0 Mil).

Medy-Tox Long-Term Debt Historical Data

The historical data trend for Medy-Tox's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medy-Tox Long-Term Debt Chart

Medy-Tox Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

177.84

65,262.97

55,056.92

20,000.00

Medy-Tox Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Long-Term Debt	Get a 7-Day Free Trial															20,000.00	15,000.00	No Debt	5,000.00	-

Medy-Tox (XKRX:086900) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Medy-Tox Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Medy-Tox's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Medy-Tox (XKRX:086900) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medy-Tox Inc (XKRX:086900) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

641-4, Gak-Ri, Ochang-Eup, Cheongwon, KOR, 363885

Website

http://www.medytox.com

Medy-Tox Inc. is a Korea-based company engaged in the development, manufacture, and marketing of biopharmaceuticals. The company's main product is type-A botulium toxin biopharmaceuticals which are used as remedies for blepharospasms, hemifacial spasms, eye wrinkles, hyperhidrosis diseases and infantile cerebral palsy. The group provides its products under the brand names of Neuronox, Siax and others. It distributes its products within Korean and to overseas markets, such as Japan, China, Russia and Europe, among others.

Medy-Tox (XKRX:086900) Headlines

No Headlines